Table: Fuji Pharmaceutical -Q1 group results

Fuji Pharma

07/02/2022 18:01

Feb 7 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Dec 31, 2021        Dec 31, 2020     Sep 30, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.45                9.30             35.97    
                 (+1.6 pct)          (+3.6 pct)       (+10.2 pct) 
  Operating         1.56                1.70              3.49    
                 (-8.0 pct)          (+61.2 pct)      (+4.2 pct)  
  Recurring         1.58                1.73              3.54    
                 (-8.7 pct)          (+59.6 pct)      (+8.9 pct)  
  Net               1.12                1.33              2.56    
                 (-15.8 pct)         (+78.3 pct)      (+5.3 pct)  
  EPS             46.05 yen           42.64 yen       105.49 yen  
  Ann Div                             29.00 yen        32.00 yen  
  -Q2 div                             14.00 yen        15.00 yen  
  -Q4 div                             15.00 yen        17.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T